| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,359,363 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$66,817,571 |
|
|
| Total
Shares |
11,359,363 |
|
|
| Total
Value |
$66,817,571 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
5
|
|
Stock
price went up :
|
64
|
3
|
| Stock
price went down : |
59
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.5
|
| Percentage
Gain/Loss : |
 14.2%
|
 -54.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-17 |
126,050 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-10 |
4 |
S |
$3.11 |
$472,424 |
I/I |
(151,700) |
2,380,294 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$16.87 |
$5,061,000 |
I/I |
300,000 |
2,408,472 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-30 |
4 |
B |
$16.00 |
$800,000 |
I/I |
50,000 |
2,458,472 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-20 |
4 |
B |
$6.49 |
$4,562 |
I/I |
703 |
2,496,209 |
1.42 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-02 |
4 |
B |
$5.69 |
$110,339 |
I/I |
19,400 |
2,519,400 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-09 |
4 |
S |
$3.09 |
$94,526 |
I/I |
(30,600) |
2,531,994 |
0 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-03 |
4 |
B |
$5.74 |
$118,308 |
I/I |
20,600 |
2,540,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-04 |
4 |
B |
$5.79 |
$57,861 |
I/I |
10,000 |
2,550,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-06-19 |
4 |
B |
$5.58 |
$195,402 |
I/I |
35,000 |
2,585,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-05-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,599,100 |
|
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-07 |
4 |
B |
$5.18 |
$213,996 |
I/I |
41,300 |
2,626,300 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-08 |
4 |
B |
$4.99 |
$324,630 |
I/I |
65,000 |
2,691,300 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-10 |
4 |
B |
$4.98 |
$223,965 |
I/I |
45,000 |
2,761,300 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2020-07-11 |
4 |
B |
$4.96 |
$231,922 |
I/I |
46,800 |
2,808,100 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-01-28 |
4 |
B |
$2.20 |
$1,100 |
I/I |
500 |
2,820,500 |
1.42 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-03-16 |
4 |
B |
$2.20 |
$4,917 |
I/I |
2,235 |
2,837,735 |
1.42 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-19 |
4 |
B |
$14.65 |
$205,366 |
I/I |
14,017 |
3,614,017 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-20 |
4 |
B |
$14.49 |
$86,710 |
I/I |
5,983 |
3,620,000 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2020-03-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,640,000 |
|
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-11-15 |
4 |
B |
$8.03 |
$200,735 |
I/I |
25,000 |
3,645,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-20 |
4 |
B |
$9.65 |
$488,290 |
I/I |
50,600 |
3,695,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-28 |
4 |
B |
$12.82 |
$641,000 |
I/I |
50,000 |
3,745,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-19 |
4 |
B |
$10.56 |
$310,391 |
I/I |
29,400 |
3,775,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-06-21 |
4 |
B |
$1.31 |
$1,105,279 |
I/I |
841,989 |
3,776,589 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
B |
$10.29 |
$120,547 |
I/I |
11,715 |
3,786,715 |
1.5 |
% |
|
158 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
